Insider · CIK 0001995275

Lennon David James

Reports to the SEC for 1 company · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001995275

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+194K sh	—	—	193,957
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+194K sh	—	—	193,957
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Stock option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+194K sh	—	—	193,957
2026-09-15	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+194K sh	—	—	193,957
2026-05-14	WHWKWhitehawk Therapeutics, Inc.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+51K sh	$3.92	+$200K	569,643
2026-04-09	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−14.5K sh	$3.38	−$49K	518,622
2026-04-08	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−63.9K sh	$3.40	−$217K	533,122
2026-04-07	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−94.1K sh	$3.43	−$323K	597,067
2026-04-06	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−102K sh	$3.51	−$359K	691,154
2026-04-02	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−26.9K sh	$3.48	−$93.5K	793,549
2026-04-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+776K sh	—	—	820,407
2026-04-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−776K sh	—	—	0
2026-04-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+831K sh	—	—	831,148
2026-03-02	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,100 sh	$3.31	−$16.9K	44,579
2026-03-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+16.3K sh	—	—	49,679
2026-03-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−16.3K sh	—	—	32,500
2025-04-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+776K sh	—	—	775,828
2025-04-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+776K sh	—	—	775,828
2025-03-03	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,690 sh	$2.35	−$13.4K	33,429
2025-03-01	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+16.3K sh	—	—	39,119
2025-03-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−16.3K sh	—	—	48,750
2024-10-03	WHWKWhitehawk Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,689 sh	$1.94	−$18.8K	22,869
2024-10-02	WHWKWhitehawk Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+32.6K sh	—	—	32,558
2024-10-02	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−32.6K sh	—	—	0
2024-03-01	WHWKWhitehawk Therapeutics, Inc. · Stock option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+30.8K sh	—	—	30,768
2024-03-01	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+130K sh	—	—	130,000
2024-03-01	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+65K sh	—	—	65,000
2023-10-02	WHWKWhitehawk Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+32.6K sh	—	—	32,558
2023-10-02	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+490K sh	—	—	490,000

Recent filings

Accepted (ET)
Sep 184/A
Lennon David James0001995275-26-000018
SEC(opens sec.gov)
Sep 154
Lennon David James0001995275-26-000016
SEC(opens sec.gov)
May 184
Lennon David James0001995275-26-000014
SEC(opens sec.gov)
Apr 104
Lennon David James0001995275-26-000012
SEC(opens sec.gov)
Apr 84
Lennon David James0001995275-26-000008
SEC(opens sec.gov)
Apr 34
Lennon David James0001995275-26-000006
SEC(opens sec.gov)
Mar 104
Lennon David James0001995275-26-000002
SEC(opens sec.gov)
Apr 34
Lennon David James0001415889-25-010076
SEC(opens sec.gov)
Mar 34
Lennon David James0001415889-25-006316
SEC(opens sec.gov)

Companies

Whitehawk Therapeutics, Inc.Director, CHIEF EXECUTIVE OFFICERWHWK

Address

C/O WHITEHAWK THERAPEUTICS, INC. 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T

MORRISTOWN, NJ, 07960